Abstract
development, dose climatology, and initial validation” by Mertens et al. Yehoshua Socol, Jerry M. Cuttler, Ludwik Dobrzynski, Mohan Doss, Ludwig E. Feinendegen, Krzysztof W. Fornalski, Marek K. Janiak, Mark L. Miller, Kanokporn Noy Rithidech, Charles L. Sanders, Bobby R. Scott, Brant Ulsh, Alexander Vaiserman, and James Welsh Falcon Analytics, Karney Shomron, Israel, Cuttler & Associates Inc., Mississauga, Ontario, Canada, Education & Training Division, National Center for Nuclear Research, Świerk, Poland, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA, Heinrich-Heine University, Dusseldorf, Germany, Polish Nuclear Society, Warszawa, Poland, Department of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology, Warsaw, Poland, Sandia National Laboratories, Albuquerque, New Mexico, USA, Department of Pathology, Stony Brook University, Stony Brook, New York, USA, Department of Nuclear and Quantum Engineering, KAIST, Daejeon, South Korea and Loveland, Colorado, USA, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA, M.H. Chew & Associates, Cincinnati, Ohio, USA, Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine, Northern Illinois University, DeKalb, Illinois, USA, Fermi National Accelerator Laboratory, Batavia, Illinois, USA
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call